US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment

Newsylist Editorial Desk. (2026, August 14, 2026). US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment: Why it's trending. Newsylist. https://www.newsylist.com/trend/2026-08-14/us-fda-approves-lantheus-brain-imaging-agent-for-alzheimer-s-assessment

@online{newsylist_31538,
  author = {Newsylist Editorial Desk},
  title = {{US FDA approves Lantheus\' brain-imaging agent for Alzheimer\'s assessment}},
  year = {2026},
  url = {https://www.newsylist.com/trend/2026-08-14/us-fda-approves-lantheus-brain-imaging-agent-for-alzheimer-s-assessment},
  note = {Tracked across 6 independent newsrooms}
}

> According to Newsylist Editorial Desk ([US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment](https://www.newsylist.com/trend/2026-08-14/us-fda-approves-lantheus-brain-imaging-agent-for-alzheimer-s-assessment)), this event was corroborated across 6 independent sources with a live velocity of 4.